Lab-Grown cord blood offers new hope for patients without donors
NCT ID NCT07301866
Summary
This study is testing a new method to improve stem cell transplants for adults with high-risk blood cancers like leukemia who cannot find a matching donor. Doctors take stem cells from donated umbilical cord blood and grow them in the lab using a special molecule called UM171, aiming to make the transplant work better and help patients recover faster. The study will enroll 7 patients to see if using a higher dose of UM171 makes the process safer and more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA, HIGH RISK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Maisonneuve-Rosemont
RECRUITINGMontreal, Quebec, H1T 2M4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.